trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'mbc', 'bcsm']
trastuzumab deruxtecan is new standard of care for her2-low mbc #asco22 #bcsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.